Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Hum Fertil (Camb) ; 26(6): 1503-1510, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38248811

ABSTRACT

The influence of cola intake on birth outcomes is unclear. This study sought to describe and compare the associations between cola intake and adverse birth outcomes among women following assisted reproductive technology (ART) and women spontaneously conceived (SC). Participants (736 ART women and 1,270 SC women) were from the Chinese National Birth Cohort collected in Anhui province. Cola intake was assessed by self-reported questionnaires at each trimester. Outcome measures including preterm birth (PTB) and low birth weight (LBW) were extracted from medical records. The association between cola intake during pregnancy and PTB was found using multivariable log-binomial regression in combined ART and SC women. Separately, for ART women, cola intake during pregnancy increased the risk of PTB (risk ratios were 2.10, 1.65, and 1.81 for all three trimesters, respectively, all p < 0.05), and cola intake in the 1st trimester increased the risk of LWB (risk ratio 2.58, 95% confidence interval 1.29 to 5.16). Cola intake during pregnancy was not associated with PTB or LBW for SC women. Our findings indicate a detrimental effect of cola intake during pregnancy on birth outcomes for ART women. Thus, avoidance of cola intake should be counselled by medical doctors in women prescribed with ART treatment.


Subject(s)
Carbonated Beverages , Cola , Pregnancy , Premature Birth , Reproductive Techniques, Assisted , Female , Humans , Infant, Newborn , Pregnancy/drug effects , Asian People , Cohort Studies , Premature Birth/epidemiology , Premature Birth/etiology , Reproductive Techniques, Assisted/adverse effects , Carbonated Beverages/adverse effects , Cola/adverse effects , Pregnancy Outcome
2.
PLoS One ; 16(3): e0247573, 2021.
Article in English | MEDLINE | ID: mdl-33684143

ABSTRACT

Kola nut (from Cola nitida) is popular in Nigeria and West Africa and is commonly consumed by pregnant women during the first trimester to alleviate morning sickness and dizziness. There is, however, a dearth of information on its effects on the developing brain. This study, therefore, investigated the potential effects of kola nut on the structure of the developing neonatal and juvenile cerebellum in the rat. Pregnant Wistar rats were administered water (as control) or crude (aqueous) kola nut extract at 400, 600, and 800 mg/kg body weight orally, from pregnancy to day 21 after birth. On postnatal days 1, 7, 14, 21 and 28, the pups were weighed, anaesthetised, sacrificed and perfused with neutral buffered formalin. Their brains were dissected out, weighed and the cerebellum preserved in 10% buffered formalin. Paraffin sections of the cerebellum were stained with haematoxylin and eosin for cerebellar cytoarchitecture, cresyl violet stain for Purkinje cell count, Glial Fibrillary Acidic Protein (GFAP) immunohistochemistry (IHC) for estimation of gliosis, and B-cell lymphoma 2 (Bcl-2) IHC for apoptosis induction. The kola nut-treated rats exhibited initial reduction in body and brain weights, persistent external granular layer, increased molecular layer thickness, and loss of Bergmann glia. Their Purkinje cells showed reduction in density, loss of dendrites and multiple layering, and their white matter showed neurodegeneration (spongiosis) and GFAP and Bcl-2 over-expression, with evidence of reactive astrogliosis. This study, therefore, demonstrates that kola nut, administered repeatedly at certain doses to pregnant dams, could disrupt normal postnatal cerebellar development in their pups. The findings suggest potential deleterious effects of excessive kola nut consumption on human brain and thus warrant further studies to understand the wider implications for human brain development.


Subject(s)
Cerebellum/drug effects , Cerebellum/pathology , Cola/adverse effects , Plant Extracts/adverse effects , Administration, Oral , Animals , Animals, Newborn , Apoptosis/drug effects , Behavior, Animal/drug effects , Body Weight/drug effects , Cerebellum/metabolism , Female , Glial Fibrillary Acidic Protein/analysis , Glial Fibrillary Acidic Protein/metabolism , Male , Nigeria , Plant Extracts/administration & dosage , Pregnancy , Proto-Oncogene Proteins c-bcl-2/metabolism , Purkinje Cells/drug effects , Purkinje Cells/metabolism , Purkinje Cells/pathology , Rats , Rats, Wistar
3.
J Clin Pediatr Dent ; 41(4): 294-299, 2017.
Article in English | MEDLINE | ID: mdl-28650789

ABSTRACT

OBJECTIVE: To examine the effects of cola-flavored beverages and caffeine on growth and metabolism of Streptococcus mutans biofilm. This study was designed to determine if carbonated beverages or caffeine can increase S. mutans growth and biofilm formation and metabolic activity in vitro, potentially leading to increased S. mutans-associated cariogenicity in children that consume them. STUDY DESIGN: Six different cola-flavored products, plus pure caffeine, and pure high fructose corn syrup (HFCS), at different concentrations similar to those in the beverages were tested. A 16-hour culture of S. mutans was treated with different dilutions in bacteriological media. To test for the effect on biofilm formation, the biofilm was stained with crystal violet. The absorbance was determined to evaluate biofilm growth. Biofilm metabolic activity was measured based on biofilm having the ability to reduce XTT to a water-soluble orange compound. RESULTS: The inclusion of HFCS in the beverages, as well as pure HFCS, significantly enhanced bacterial biofilm formation and metabolic activity. Pure caffeine and the presence of caffeine in beverages did not significantly increase biofilm formation, but pure caffeine significantly increased metabolism, and Diet Coke had significantly greater metabolic activity than Caffeine-Free Diet Coke. CONCLUSIONS: HFCS increases both the biofilm formation and metabolism of S. mutans, and caffeine in some cases increases metabolism of S. mutans.


Subject(s)
Biofilms/growth & development , Caffeine/pharmacology , Carbonated Beverages/adverse effects , Cariogenic Agents/adverse effects , Cola/adverse effects , High Fructose Corn Syrup/pharmacology , Streptococcus mutans/growth & development , Streptococcus mutans/metabolism , Dose-Response Relationship, Drug , Humans , Oxidation-Reduction/drug effects
5.
J Oral Sci ; 52(4): 553-9, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21206156

ABSTRACT

This in vitro study aimed to analyze the effects of application of xylitol varnishes and solutions to protect against enamel erosion. Twelve bovine enamel specimens were pre-treated with 5% NaF-Duraphat varnish, 10% xylitol varnish, 20% xylitol varnish, placebo varnish, 5% NaF solution, 10% xylitol solution or 20% xylitol solution. The varnishes and solutions were applied for 6 h and 1 min, respectively. Controls remained untreated (n = 12). Specimens were then subjected to erosive demineralization (Coca-Cola, 4 × 90 s/d) and remineralization (artificial saliva, 2 h) cycling for 10 days. After 5 days, the varnishes and solutions were reapplied. After reapplication, two specimens per group were analyzed by SEM. Enamel loss was measured profilometrically after the 5th and 10th days. Data were then analyzed statistically by ANOVA and Tukey's post-hoc test (n = 10, P < 0.05). After the 5th day, all varnishes and 20% xylitol solution significantly reduced the enamel loss when compared to the placebo varnish/control. After 10 days of erosive pH cycling, both xylitol varnishes and solutions significantly reduced the enamel erosion when compared with the control. However, 10% xylitol solution produced a smooth layer on eroded enamel and significantly reduced the enamel erosion when compared to the placebo varnish/control. Xylitol thus appears to be a good option to partially reduce enamel erosion.


Subject(s)
Tooth Erosion/prevention & control , Xylitol/therapeutic use , Analysis of Variance , Animals , Carbonated Beverages/adverse effects , Cattle , Cola/adverse effects , Dental Enamel/pathology , Fluorides, Topical/therapeutic use , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Paint , Sodium Fluoride/therapeutic use , Statistics, Nonparametric , Tooth Erosion/etiology , Xylitol/administration & dosage
6.
Br J Clin Pharmacol ; 70(5): 762-4, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21545633

ABSTRACT

AIMS: To report a case of severe delayed methotrexate elimination attributable to consumption of a cola beverage. METHODS: To investigate unexplained low urinary pH in a lymphoma patient treated with high-dose methotrexate. RESULTS: Unexpected urinary acidity, despite administration of large amounts of sodium bicarbonate, could be attributed to repeated consumption of a cola beverage. It resulted in a delayed elimination of methotrexate and acute renal failure. Discontinuation of cola drinks, increase in calcium folinate rescue and in sodium bicarbonate allowed satisfactory elimination of methotrexate on day 12 after infusion and recovery from renal impairment without other severe toxicity. No other cause of delay in methotrexate elimination could be identified. CONCLUSIONS: Cola beverages have a low pH due to their phosphoric acid content that is excreted by renal route. We recommend patients receiving high dose methotrexate abstain from any cola drink within 24 h before and during methotrexate administration and until complete elimination of the drug.


Subject(s)
Carbonated Beverages/adverse effects , Cola/adverse effects , Food-Drug Interactions , Methotrexate/pharmacokinetics , Antimetabolites, Antineoplastic , Biological Transport/drug effects , Humans , Hydrogen-Ion Concentration , Kidney/metabolism , Liver/metabolism , Lymphoma/drug therapy , Lymphoma/urine , Male , Methotrexate/therapeutic use , Middle Aged , Urine/chemistry
7.
Afr J Tradit Complement Altern Med ; 7(1): 47-52, 2009 Oct 15.
Article in English | MEDLINE | ID: mdl-21304612

ABSTRACT

The study investigated the microanatomical effects of the extracts of Cola nitida on the stomach mucosa of adult male Wistar rats. Twenty adult male wistar rats were randomly divided into four equal groups of A, B, C and D (n = 5). Animals in experimental groups B, C and D were given 600 mg/kg body weight of crude extract of Cola nitida each by oral intubation for five, seven and nine consecutive days respectively, while group A (control) received equivalent volume of distilled water. Twenty four hrs after the last administration, the animals were sacrificed; tissues were harvested and fixed in 10% formol saline for histological analysis. The study revealed necrotized surface epithelium, degenerated gastric mucosa, and loss of glandular elements in the stomachs of experimental groups' vis-à-vis the control group. These observations were days-dependent; as those groups which received the extract for higher number of days were seen to be adversely affected. In conclusion, Cola nitida at 600 mg/kg body weight can cause gastric lesion in animals. This lesion may be pronounced if the administration continued for days. Cola nitida should, therefore, be taken with caution to avoid gastric complications.


Subject(s)
Cola/chemistry , Gastric Mucosa/drug effects , Nuts , Plant Extracts/pharmacology , Animals , Cola/adverse effects , Ethanol , Gastric Mucosa/ultrastructure , Male , Microscopy , Random Allocation , Rats , Rats, Wistar , Stomach Ulcer/chemically induced
9.
Epidemiology ; 18(4): 501-6, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17525693

ABSTRACT

BACKGROUND: Carbonated beverage consumption has been linked with diabetes, hypertension, and kidney stones, all risk factors for chronic kidney disease. Cola beverages, in particular, contain phosphoric acid and have been associated with urinary changes that promote kidney stones. METHODS: We examined the relationship between carbonated beverages (including cola) and chronic kidney disease, using data from 465 patients with newly diagnosed chronic kidney disease and 467 community controls recruited in North Carolina between 1980 and 1982. RESULTS: Drinking 2 or more colas per day was associated with increased risk of chronic kidney disease (adjusted odds ratio = 2.3; 95% confidence interval = 1.4-3.7). Results were the same for regular colas (2.1; 1.3-3.4) and artificially sweetened colas (2.1; 0.7-2.5). Noncola carbonated beverages were not associated with chronic kidney disease (0.94; 0.4-2.2). CONCLUSIONS: These preliminary results suggest that cola consumption may increase the risk of chronic kidney disease.


Subject(s)
Carbonated Beverages/adverse effects , Cola/adverse effects , Feeding Behavior , Kidney Failure, Chronic/epidemiology , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged , North Carolina/epidemiology , Odds Ratio , Risk Factors
10.
Int J Obes Relat Metab Disord ; 26(5): 593-604, 2002 May.
Article in English | MEDLINE | ID: mdl-12032741

ABSTRACT

OBJECTIVE: To examine long-term safety and efficacy for weight loss of an herbal Ma Huang and Kola nut supplement (90/192 mg/day ephedrine alkaloids/caffeine). DESIGN: Six-month randomized, double-blind placebo controlled trial. SUBJECTS: A total of 167 subjects (body mass index (BMI) 31.8+/-4.1 kg/m(2)) randomized to placebo (n=84) or herbal treatment (n=83) at two outpatient weight control research units. MEASUREMENTS: Primary outcome measurements were changes in blood pressure, heart function and body weight. Secondary variables included body composition and metabolic changes. RESULTS: By last observation carried forward analysis, herbal vs placebo treatment decreased body weight (-5.3+/-5.0 vs. -2.6+/-3.2 kg, P<0.001), body fat (-4.3+/-3.3 vs. -2.7+/-2.8 kg, P=0.020) and LDL-cholesterol (-8+/-20 vs. 0+/-17 mg/dl, P=0.013), and increased HDL-cholesterol (+2.7+/-5.7 vs. -0.3+/-6.7 mg/dl, P=0.004). Herbal treatment produced small changes in blood pressure variables (+3 to -5 mm Hg, P< or =0.05), and increased heart rate (4+/-9 vs. -3+/-9 bpm, P<0.001), but cardiac arrhythmias were not increased (P>0.05). By self-report, dry mouth (P<0.01), heartburn (P<0.05), and insomnia (P<0.01) were increased and diarrhea decreased (P<0.05). Irritability, nausea, chest pain and palpitations did not differ, nor did numbers of subjects who withdrew. CONCLUSIONS: In this 6-month placebo-controlled trial, herbal ephedra/caffeine (90/192 mg/day) promoted body weight and body fat reduction and improved blood lipids without significant adverse events.


Subject(s)
Caffeine/therapeutic use , Ephedra , Ephedrine/therapeutic use , Plant Preparations/therapeutic use , Weight Loss , Blood Glucose/analysis , Blood Pressure/drug effects , Body Composition , Body Weight , Caffeine/administration & dosage , Caffeine/adverse effects , Cholesterol/blood , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cola/adverse effects , Dietary Supplements , Electrocardiography, Ambulatory , Ephedra/adverse effects , Ephedra/chemistry , Ephedra sinica/adverse effects , Ephedrine/administration & dosage , Ephedrine/adverse effects , Heart Rate/drug effects , Humans , Patient Compliance , Placebos , Plant Preparations/administration & dosage , Plant Preparations/adverse effects , Prospective Studies , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...